• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DEXCOM, INC. DEXCOM G7 CONTINUOUS GLUCOSE MONITORING SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DEXCOM, INC. DEXCOM G7 CONTINUOUS GLUCOSE MONITORING SYSTEM Back to Search Results
Model Number 9501-161
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Rash (2033); Skin Infection (4544)
Date of Event 02/22/2026
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
(b)(4).Labeling indicates: inserting the sensor and wearing the adhesive patch might cause infection, bleeding, pain or skin irritations (e.G.Redness, swelling, bruising, itching, scarring or skin discoloration).
 
Event or Problem Description
It was reported that a skin reaction occurred.The sensor was inserted into the arm on (b)(6) 2026.Prior to sensor insertion the area was prepped with alcohol.According to the reporter, on (b)(6) 2026, the pediatric patient experienced a skin reaction with pustules and an infection at the needle puncture site.Photos of the reported skin reaction in the complaint record were reviewed.The reaction was confirmed and is consistent with similar local skin responses previously observed and assessed in association with the device use.The findings are within the expected range of reactions known to occur at or around the device application area.There is no documentation of scarring, or systemic involvement.The image shows a localized circular area of erythema at a prior sensor insertion site with a small lesion.The surrounding skin appears intact with mild redness and faint residual markings consistent with prior adhesive use.No open wound, drainage, blistering, or ulceration is visible.The patient visited an healthcare provider and was prescribed an oral antibiotic flucloxacillin (250mg/5ml 4x a day).There was no documentation of further medical intervention.At the time of the report, the patient¿s condition is fine.No data or product was provided for investigation; however, a photograph was provided.The allegation was confirmed via photographic inspection.The probable cause could not be determined.No additional patient or event information is available.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DEXCOM G7 CONTINUOUS GLUCOSE MONITORING SYSTEM
Common Device Name
CONTINUOUS GLUCOSE MONITOR
Manufacturer (Section D)
DEXCOM, INC.
6340 sequence dr.
san diego CA 92121
Manufacturer (Section G)
DEXCOM, INC.
pmt 818
persiaran cassia selatan 3
bandar cassia 14110
MY   14110
Manufacturer Contact
jaime chavez
6340 sequence dr.
san diego, CA 92121
8582000200
MDR Report Key24738025
Report Number3004753838-2026-122712
Device Sequence Number9840320
Product Code QBJ
UDI-Device Identifier00386270004048
UDI-Public(01)00386270004048(11)251101(17)270430(10)1825336014
Combination Product (Y/N)N
Initial Reporter CountryGB
PMA/510(K) Number
K213919
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Consumer
Initial Reporter Occupation Other
Type of Report Initial
Report Date (Section B) 03/30/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Lay User/Patient
Device Model Number9501-161
Device Catalogue NumberSTP-GT-001
Device Lot Number1825336014
Was Device Available for Evaluation? No
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 03/17/2026
Initial Report FDA Received Date03/31/2026
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured11/01/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
INSULET OMNIPOD5.; ORAL ANTIBIOTIC.
Outcome Attributed to Adverse Event Other;
Patient Age10 YR
Patient SexMale
-
-